However, abnormal activation of AIM2‐mediated immune response in response to cellular perturbations has been reported to cause immune‐linked disorders such as systemic lupus erythematosus (SLE),7 psoriasis,8 primary Sjogren's syndrome,9, 10 and polyarthritis.11 This evidence concerns the gene AIM2 and psoriasis.